1. Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab. (7th November 2013) Authors: Forero, Andres; Hamadani, Mehdi; Kipps, Thomas; Fanale, Michelle; Cuneo, Antonio; Perez de Oteyza, Jaime; Gladstone, Douglas; Andre, Marc; Bellam, Naresh; Goswami, Trishna; Ibrahim, Ramy; Schneider, Amy; Liang, Meina; Eck, Steven; Elgeioushi, Nairouz; Herbst, Ronald; Cheson, Bruce D Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗